Applications and challenges of glucocorticoids for anti-neutrophil cytoplasmic antibody-associated vasculitis
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis are a diverse group of systemic autoimmune disorders characterized by the presence of ANCA in sera, involving frequently kidney and lung. Its etiology and pathogenesis are not fully elucidated. Although existing treatment with glucoco...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2022-12-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2022.12.011 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis are a diverse group of systemic autoimmune disorders characterized by the presence of ANCA in sera, involving frequently kidney and lung. Its etiology and pathogenesis are not fully elucidated. Although existing treatment with glucocorticoids plus immunosuppressant has greatly improved the prognosis, it is prone to relapse after remission and often accompanied by serious adverse events. Basic treatment of glucocorticoids lacks uniformity and standardization in its applications and it is a major factor of treatment-related adverse events. This review summarized the applications of glucocorticoids for ANCA-associated vasculitis to provide references for clinical practices. |
|---|---|
| ISSN: | 1671-2390 |